For example, in vitro and vivo experiments showed that overexpression of RRM2 promoted epithelial-mesenchymal transition, whereas knockdown of RRM2 inhibited its oncogenic function in prostate cancer [25]. This evidence concerns the gene RRM2 and prostate cancer.